Vudalimab

(Synonyms: XmAb20717)
Kundenbewertung

Based on 1 Customer Validation

Vudalimab (XmAb20717) is a bispecific antibody that binds PD-1 and CTLA-4. Vudalimab preferentially binds to cells co-expressing PD-1 and CTLA-4 and blocks inhibitory checkpoint signaling to promote T cell activation. Vudalimab can be used for research in metastatic castration-resistant prostate cancer (including high-risk disease) and gynecological malignancies.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : ≥99.0%
  • CAS. Nr.: 2329669-72-7
  • Molecular Weight:144.5 kDa
  • Speicherung:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00